BioScience Health Innovations, operating as Best 365 Labs through its wholly owned subsidiary, sells nutritional supplements focused on cellular and mitochondrial health, including products targeting immune health, NAD+ restoration, testosterone optimization, and metabolic wellness. The company sells primarily direct-to-consumer via its website, with additional distribution through wholesale and Amazon channels. The core of the business is MODS Max (Mineral Oxide Delivery System), a patent-pending delivery technology designed to increase the bioavailability of supplements by transiently opening tight junctions in mucosal membranes. The company claims conventional oral supplements deliver only 10–20% of active ingredients, and that MODS Max achieves meaningfully higher absorption across sublingual, oral, nasal, and topical formats. MODS Max underpins all current product lines, including its flagship sublingual testosterone product (NHTO/TPrime365) and its NAD+ line, and management argues the technology could eventually convert injection-only compounds — including GLP-1 therapeutics and peptides — into oral or sublingual formats. Beyond direct product sales, the company is pursuing two additional revenue streams: licensing MODS Max to pharmaceutical companies and compounding pharmacies, and building pharmacy partnerships to distribute testosterone and peptide formulations through clinical channels. The company is early-stage, and a pending settlement with related party Ageless Holdings is expected to transfer rights to 30+ additional proprietary formulations covering peptides, GLP-1 therapeutics, and longevity protocols, none of which are yet commercialized.